LabCorp is Scheduled to Present at the Barclays Capital 2012 Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 7, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the Barclays Capital 2012 Global Healthcare Conference in Miami Beach, FL.

LabCorp is Scheduled to Speak at RBC Capital Markets’ 2012 Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 22, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the RBC Capital Markets’ 2012 Global Healthcare Conference in New York City ,

Laboratory Corporation of America® Holdings Announces 2011 Fourth Quarter and Full Year Results

Revenue Growth Drives Q4 Diluted EPS of $1.34 and Adjusted EPS Excluding Amortization of $1.56 ; Board Authorizes New $500 Million Share Repurchase Program BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 10, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced

LabCorp to Offer New FDA Cleared Test to Aid in Assessing Whether Ovarian Mass is at High or Low Likelihood of Being Malignant

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 18, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today the nationwide availability of a new FDA cleared risk stratification tool ( ROMA ® , R isk of O varian M alignancy A lgorithm) that combines the results for

LabCorp is Scheduled to Present at the 30th Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 4, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the 30 th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 3, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

LabCorp(R) Enters into New Credit Facility Totaling $1.0 Billion

BURLINGTON, N.C., Dec 21, 2011 (BUSINESS WIRE) --Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) today announced that it has entered into a new senior unsecured credit facility totaling $1.0 billion. Bank of America, N.A. will act as Administrative Agent and Barclays

LabCorp Successfully Completes Acquisition of Orchid Cellmark Inc.

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 16, 2011-- Laboratory Corporation of America® Holdings (NYSE: LH) today announced the successful completion of the previously announced subsequent offering period for the cash tender offer by its wholly owned subsidiary, OCM Acquisition Corp.

LabCorp Successfully Completes Tender Offer for Orchid Cellmark and Commences Subsequent Offering Period to Allow for Additional Tenders

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 12, 2011-- Laboratory Corporation of America® Holdings (NYSE: LH) today announced the successful completion of the cash tender offer by its wholly owned subsidiary, OCM Acquisition Corp. , for all outstanding shares of common stock of Orchid Cellmark Inc.

U.S. Federal Trade Commission Approves LabCorp’s Acquisition of Orchid Cellmark

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 8, 2011-- Laboratory Corporation of America® Holdings (NYSE: LH) today announced that it has reached an agreement with the U.S. Federal Trade Commission allowing LabCorp to complete its acquisition of Orchid Cellmark Inc (NASDAQ: ORCH).